Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide
- PMID: 38986908
- DOI: 10.1016/j.amjms.2024.06.030
Diabetes with GLP-1R polymorphism (rs3765467) accompanied by myotonic dystrophy: A case of myotonic dystrophy with p.R131Q polymorphism at the glucagon-like peptide-1 receptor (rs3765467) resulting in marked effects of its agonist, dulaglutide
Abstract
A 47-year-old woman was diagnosed with myotonic dystrophy when admitted for traumatic subarachnoid hemorrhage. Her glycemic control was poor despite administration of pioglitazone, a PPARɤ agonist, and subcutaneous insulin infusion. However, adding a GLP-1 receptor (GLP-1R) agonist markedly improved blood glucose levels, resulting in eventual insulin withdrawal. Genetic testing revealed a heterozygous variant, p.R131Q, in the GLP1R (rs3765467), a common variant in Asia. This variant is known to be associated with increased endogenous insulin from beta cells in response to exogenous GLP-1 infusion. This is the first report and short review of a Japanese case of myotonic dystrophy accompanied by GLP-1R gene polymorphism.
Keywords: Diabetes mellitus; Missense of p. R131Q polymorphism at GLP-1 receptor; Myotonic dystrophy.
Copyright © 2024 Southern Society for Clinical Investigation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetes.Ann Pharmacother. 2015 Mar;49(3):351-9. doi: 10.1177/1060028014564180. Epub 2015 Jan 6. Ann Pharmacother. 2015. PMID: 25565404 Review.
-
Differential effects of once-weekly glucagon-like peptide-1 receptor agonist dulaglutide and metformin on pancreatic β-cell and insulin sensitivity during a standardized test meal in patients with type 2 diabetes.Diabetes Obes Metab. 2016 Aug;18(8):834-9. doi: 10.1111/dom.12671. Epub 2016 May 16. Diabetes Obes Metab. 2016. PMID: 27059816
-
GLP-1 receptor agonist-induced diabetic ketoacidosis: A case report.Medicine (Baltimore). 2024 Sep 27;103(39):e39799. doi: 10.1097/MD.0000000000039799. Medicine (Baltimore). 2024. PMID: 39331877 Free PMC article.
-
[Dulaglutide (Trulicity®), a new once-weekly agonist of glucagon-like peptide-1 receptors for type 2 diabetes].Rev Med Liege. 2016 Mar;71(3):154-60. Rev Med Liege. 2016. PMID: 27311248 French.
-
Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?Diabetes Metab Res Rev. 2019 Jan;35(1):e3070. doi: 10.1002/dmrr.3070. Epub 2018 Oct 4. Diabetes Metab Res Rev. 2019. PMID: 30156747 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources